1. Abraham, K., Knoll, A., Ende, M., Papke, O., and Helge, H. (1996). Intake, fecal excretion, and body burden of polychlorinated dibenzo-p-dioxins and dibenzofurans in breast-fed and formula-fed infants. Pediatr. Res.40(5), 671–679.
2. Alcorn, J., and McNamara, P. J. (2003). Pharmacokinetics in the newborn. Adv. Drug Deliv. Rev.55,667–686.
3. Andersen, M. E., Gargas, M. L., Hays, S. M., Clewell, H. J., III, and Paustenbach, D. J. (1997). Estimating minimally effective inducing doses (ED01s) of TCDD in livers of rats and humans using physiologically based pharmacokinetic modeling. Organohalogen Compounds34,311–316.
4. Andersen, M., Clewell, H., Gargas, M., Smith, F., and Reitz, R. (1987). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol.87(2), 185–205.
5. Åstrand, I. (1983). Effect of physical exercise on uptake, distribution and elimination of vapors in man. In Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination (Fiserova-Bergerova V, Ed.), Vol. 2, pp. 107–130. CRC Press, Boca Raton, FL.